Impaired glucose tolerance in patients with acute myocardial infarction;Nedsatt glukosetoleranse hos pasienter med akutt hjerteinfarkt

Tidsskrift for den Norske Laegeforening

Volumn 126, Issue 17, 2006, Pages 2264-2267

  Andersen, Geir Øystein ^a,b   Eritsland, Jan ^a   Aasheim, Anders ^a   Neuburger, Jacob ^a   Knudsen, Eva Cecilie ^a   Mangschau, Arild ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 33748748117     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Norhammar A, Tenerz A, Nilsson G et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-4.
2. Bartnik M, Ryden L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-90.
3. Bartnik M, Malmberg K, Norhammar A et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-7.
4. Report of the WHO Consultation D, diagnosis and classification of diabetes mellitus and its complications. Part 1 Diagnosis and classification of diabetes mellitus. Genève: World Health Organization, Department of Noncommunicable Disease Surveillance, 1999. www.staff.ncl.ac.uk/philip.home/ who_dmg.pdf. (12.5.2006).
5. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006; 21: 1-6.
6. Midthjell K, Bjorndal A, Holmen J et al. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trøndelag Diabetes Study. Scand J Prim Health Care 1995; 13: 229-35.
7. Foy CG, Bell RA, Farmer DF et al. Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2005; 28: 2501-7.
8. Wen CP, Cheng TY, Tsai SP et al. Exploring the relationships between diabetes and smoking: With the development of «glucose equivalent» concept for diabetes management. Diabetes Res Clin Pract 2006; 73: 70-6.
9. Melberg T, Thoresen M, Hansen JB et al. Hvordan behandles pasienter med akutt koronarsyndrom i norske sykehus? Tidsskr Nor Lægeforen 2005; 125: 2925-8.
10. Haffner SM. Glucose-tolerance testing in acute myocardial infarction. Lancet 2002; 359: 2127.
11. Stene L, Midthjell K, Jenum A et al. Hvor mange har diabetes mellitus i Norge? Tidsskr Nor Lægeforen 2004; 124: 1511-4.
12. Cruikshank N. Coronary thrombosis and myocardial infarction with glycosuria. BMJ 1931; 1: 618-9.
13. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773.
14. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-31.
15. Malmberg K, Ryden L, Wedel H et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650-1.
16. Investigators TC-ETG. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293: 437-46.
17. Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-61.
18. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.
19. Langouche L, Vanhorebeek I, Vlasselaers D et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115: 2277-86.
20. Wallander M, Bartnik M, Efendic S et al. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia 2005; 48: 2229-35.